Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

NICE rejects Pfizer’s Vyndaqel for treating rare heart condition

May 12, 2021 Research and Development NICE, Pfizer, Vyandaqel

NICE has published final guidance today which rejects tafamidis, also known as Vyndaqel, for treating rare heart condition transthyretin amyloidosis …
News

Endogena’s retinitis pigmentosa treatment granted Orphan Drug Designation by FDA

May 12, 2021 Research and Development DFA, Endogena, Orphan Drug Designation

Endogena Therapeutics Inc has been granted Orphan Drug Designation for its EA-2353 ophthalmic suspension targeting retinitis pigmentosa by the FDA. …
News

Eli Lilly and MiNA Therapeutics to collaborate on saRNA research

May 12, 2021 Research and Development Eli Lilly

Eli Lilly and MiNA Therapeutics have announced a global research collaboration to develop novel drug candidates using MiNA’s proprietary small …
News
COVID-19 virus

Pharmafile.com’s weekly COVID-19 news round-up

May 5, 2021 Research and Development COVID-19, COVID-19 vaccine, covid 19 news, covid-19 news, pharma, pharma news

The past week has seen more COVID-19 vaccine and treatment news: Moderna will supply up to 500 million jabs to …
News

Theramex releases Vitamin D gel aimed at women

May 5, 2021 Research and Development Theramex, osteoporosis, pharma, pharma news, vitamin d

Theramex has launched a new gel for Vitamin D deficiency, in the hope that it will particularly treat women experiencing …
News

UK government to invest £29.3 million on COVID-19 variant testing

May 5, 2021 Research and Development COVID-19, UK government, Vaccine, variants

The UK government has announced an investment of £29.3 million, on top of the £19.7 million already pledged, to be …
News
janssen_latest_logo_on_sign

Janssen submits MAA to EMA for novel CAR-T cell therapy

May 5, 2021 Research and Development EMA, EU, Janssen, multiple myeloma

Janssen have submitted a Marketing Authorisation Application (MAA) to the EMA seeking approval of cilta-cel, an investigational B cell maturation …
News

New HIV prevention drug application submitted to FDA

May 5, 2021 Research and Development FDA, HIV

ViiV Healthcare have initiated a rolling submission of a new drug application (NDA) with the FDA for their long-acting HIV …
News
COVID-19 virus

Pharmafile.com’s weekly COVID-19 news round-up

April 28, 2021 Research and Development COVID-19, covid 19 news, covid-19 news, news roundup, pharma, pharma news

The past week has seen plenty of COVID-19 news continue to roll in: The European Commission has sued AstraZeneca over …
News

COVID Symptom Study app reveals most common vaccine side effects

April 28, 2021 Research and Development COVID-19, Vaccine, data

An analysis of over 600,000 people’s vaccine reports has been published in The Lancet Infectious Diseases journal, in the largest …
News

Calliditas’ kidney disease drug granted priority review by FDA

April 28, 2021 Research and Development Calliditas, FDA, nephropathy, pharma, pharma news

The FDA has granted priority review for the New Drug Applicaton (NDA) for Calliditas Therapeutics’ Nefecon, for the treatment of …
News

NICE to join GetReal Institute alongside nine key healthcare players

April 28, 2021 Research and Development EU, NICE, rwe

NICE has announced it will join with nine other organisations to form the GetReal Institute, a not-for-profit multi-stakeholder enterprise, as …
News

Single dose of COVID vaccine can cut transmissions in half

April 28, 2021 Research and Development COVID-19, Public Health England, Vaccine

A Public Health England (PHE) study into the Pfizer-BioNTech and Oxford-AstraZeneca vaccines has found that a single dose of either …
News
download_2

Sheila Frame new President for the Americas at Amryt

April 27, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Biopharmaceutical company Amryt have appointed Sheila Frame as President for the Americas.
Appointment
download_1

Francesco Maria Lavino appointed CEO of F2G Ltd

April 27, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

F2G Limited has announced that Francesco Maria Lavino has been appointed Chief Executive Officer and member of the Board of …
Appointment
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026